In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition Via HMGA1 and Its Target Slug

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2016 Apr 6

PMID 27045138

Citations 126

Authors

Rachel K Hopper

Jan-Renier A J Moonen

Isabel Diebold

Aiqin Cao

Christopher J Rhodes

Nancy F Tojais

Jan K Hennigs

Mingxia Gu

Lingli Wang

Marlene Rabinovitch

Affiliations

Soon will be listed here.

Abstract

Background: We previously reported high-throughput RNA sequencing analyses that identified heightened expression of the chromatin architectural factor High Mobility Group AT-hook 1 (HMGA1) in pulmonary arterial endothelial cells (PAECs) from patients who had idiopathic pulmonary arterial hypertension (PAH) in comparison with controls. Because HMGA1 promotes epithelial-to-mesenchymal transition in cancer, we hypothesized that increased HMGA1 could induce transition of PAECs to a smooth muscle (SM)-like mesenchymal phenotype (endothelial-to-mesenchymal transition), explaining both dysregulation of PAEC function and possible cellular contribution to the occlusive remodeling that characterizes advanced idiopathic PAH.

Methods And Results: We documented increased HMGA1 in PAECs cultured from idiopathic PAH versus donor control lungs. Confocal microscopy of lung explants localized the increase in HMGA1 consistently to pulmonary arterial endothelium, and identified many cells double-positive for HMGA1 and SM22α in occlusive and plexogenic lesions. Because decreased expression and function of bone morphogenetic protein receptor 2 (BMPR2) is observed in PAH, we reduced BMPR2 by small interfering RNA in control PAECs and documented an increase in HMGA1 protein. Consistent with transition of PAECs by HMGA1, we detected reduced platelet endothelial cell adhesion molecule 1 (CD31) and increased endothelial-to-mesenchymal transition markers, αSM actin, SM22α, calponin, phospho-vimentin, and Slug. The transition was associated with spindle SM-like morphology, and the increase in αSM actin was largely reversed by joint knockdown of BMPR2 and HMGA1 or Slug. Pulmonary endothelial cells from mice with endothelial cell-specific loss of Bmpr2 showed similar gene and protein changes.

Conclusions: Increased HMGA1 in PAECs resulting from dysfunctional BMPR2 signaling can transition endothelium to SM-like cells associated with PAH.

Citing Articles

Receptor activity-modifying protein 1 regulates the differentiation of mouse skin fibroblasts by downregulating α-SMA expression via suppression of high mobility group AT-hook 1 to promote skin wound repair.

Song R, Ma J, Yin S, Wu Z, Liu C, Sun R Burns Trauma. 2025; 13():tkae068.

PMID: 39839760 PMC: 11750253. DOI: 10.1093/burnst/tkae068.

Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q Cell Commun Signal. 2025; 23(1):16.

PMID: 39789529 PMC: 11720945. DOI: 10.1186/s12964-025-02028-y.

High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.

Shinohara T, Moonen J, Chun Y, Lee-Yow Y, Okamura K, Szafron J Arterioscler Thromb Vasc Biol. 2024; 45(2):218-237.

PMID: 39723537 PMC: 11753934. DOI: 10.1161/ATVBAHA.124.321092.

The causes of pulmonary hypertension and the benefits of aerobic exercise for pulmonary hypertension from an integrated perspective.

Song Y, Jia H, Ma Q, Zhang L, Lai X, Wang Y Front Physiol. 2024; 15:1461519.

PMID: 39483752 PMC: 11525220. DOI: 10.3389/fphys.2024.1461519.

Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.

Pi H, Xia L, Boucherat O, Suresh K, Hemnes A, Bonnet S Circ Heart Fail. 2024; 17(11):e012067.

PMID: 39435559 PMC: 11576243. DOI: 10.1161/CIRCHEARTFAILURE.124.012067.

References

Cano A, Perez-Moreno M, Rodrigo I, Locascio A, Blanco M, del Barrio M . The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2(2):76-83. DOI: 10.1038/35000025. View

Rhodes C, Im H, Cao A, Hennigs J, Wang L, Sa S . RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015; 192(3):356-66. PMC: 4584250. DOI: 10.1164/rccm.201408-1528OC. View

Deng Z, Morse J, Slager S, Cuervo N, Moore K, Venetos G . Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000; 67(3):737-44. PMC: 1287532. DOI: 10.1086/303059. View

Wood L, MAHER J, Bunton T, Resar L . The oncogenic properties of the HMG-I gene family. Cancer Res. 2000; 60(15):4256-61. View

Lane K, Machado R, Pauciulo M, Thomson J, Phillips 3rd J, Loyd J . Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000; 26(1):81-4. DOI: 10.1038/79226. View

Atkinson C, Stewart S, Upton P, Machado R, Thomson J, Trembath R . Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002; 105(14):1672-8. DOI: 10.1161/01.cir.0000012754.72951.3d. View

Frid M, Kale V, Stenmark K . Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res. 2002; 90(11):1189-96. DOI: 10.1161/01.res.0000021432.70309.28. View

Rabinovitch M, Bothwell T, Hayakawa B, Williams W, Trusler G, Rowe R . Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest. 1986; 55(6):632-53. View

Pietra G, Edwards W, Kay J, Rich S, Kernis J, Schloo B . Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation. 1989; 80(5):1198-206. DOI: 10.1161/01.cir.80.5.1198. View

10.

Arciniegas E, Sutton A, ALLEN T, Schor A . Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci. 1992; 103 ( Pt 2):521-9. DOI: 10.1242/jcs.103.2.521. View

11.

Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F . High level expression of the HMGI (Y) gene during embryonic development. Oncogene. 1996; 13(11):2439-46. View

12.

Jones P, Cowan K, Rabinovitch M . Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol. 1997; 150(4):1349-60. PMC: 1858188. View

13.

Savagner P, Yamada K, Thiery J . The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol. 1997; 137(6):1403-19. PMC: 2132541. DOI: 10.1083/jcb.137.6.1403. View

14.

Chin M, Pellacani A, Wang H, Lin S, Jain M, Perrella M . Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem. 1998; 273(16):9755-60. DOI: 10.1074/jbc.273.16.9755. View

15.

Ji Y, Xu Q, Schmedtje Jr J . Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium. Circ Res. 1998; 83(3):295-304. DOI: 10.1161/01.res.83.3.295. View

16.

Song Y, Jones J, Beppu H, Keaney Jr J, Loscalzo J, Zhang Y . Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation. 2005; 112(4):553-62. PMC: 1472405. DOI: 10.1161/CIRCULATIONAHA.104.492488. View

17.

Teichert-Kuliszewska K, Kutryk M, Kuliszewski M, Karoubi G, Courtman D, Zucco L . Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 2005; 98(2):209-17. DOI: 10.1161/01.RES.0000200180.01710.e6. View

18.

Arciniegas E, Frid M, Douglas I, Stenmark K . Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007; 293(1):L1-8. DOI: 10.1152/ajplung.00378.2006. View

19.

Zeisberg E, Tarnavski O, Zeisberg M, Dorfman A, McMullen J, Gustafsson E . Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007; 13(8):952-61. DOI: 10.1038/nm1613. View

20.

Masri F, Xu W, Comhair S, Asosingh K, Koo M, Vasanji A . Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007; 293(3):L548-54. DOI: 10.1152/ajplung.00428.2006. View